Gella, Amberield M.

HRN: 23-48-01  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/07/2023
CEFTRIAXONE 1G (VIAL)
08/07/2023
08/14/2023
IV
2g
OD
T/C Acute AP
Waiting Final Action 
08/07/2023
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
08/07/2023
08/14/2023
IV
500mg
Q8
T/C Acute AP
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

 Indication:

              

 Type of Infection:

                             

           

 Compliance to guidelines:



 Initial appropriateness:



 If inappropriate:

           

 Final appropriateness:



 If inappropriate:

              

 Overall appropriateness: